Iv%2520hydrocortisone%2520for%2520acute%2520asthma

# IV Hydrocortisone for Acute Asthma ## Overview - Potent systemic corticosteroid for rapid anti-inflammatory effect in acute severe asthma exacerbations. - Onset: within 2–4 hours IV; maximal effect at 4–6 hours. - Typically reserved for patients unable to take oral medication (e.g., severe dyspnea, vomiting, or impending respiratory failure). ## Primary Indications - Acute severe asthma exacerbation (including status asthmaticus) not responding to inhaled bronchodilators and oral corticosteroids. - As an alternative to IV methylprednisolone or oral prednisolone when oral route is not feasible. ## Adult Dosing - **Loading dose:** 100–200 mg IV (slow push or infusion). - **Maintenance:** 100 mg IV every 6–8 hours **or** 200–400 mg/day as continuous infusion. - **Maximum:** 400 mg/day (higher doses not proven more effective). - **Duration:** Usually ≤5 days; transition to oral prednisone/prednisolone once stable (no taper needed if course <7 days). - *Exact dosing may vary by local protocol.* ## Pediatric Dosing - **Loading dose:** 4–5 mg/kg IV (maximum 200 mg per dose). - **Maintenance:** 4–5 mg/kg/day IV divided every 6 hours (maximum 200 mg/day). - **Alternative regimen:** 2 mg/kg loading dose then 2 mg/kg/day divided every 6 hours for mild–moderate exacerbations. - **Duration:** 3–5 days, then convert to oral prednisolone 1–2 mg/kg/day (max 60 mg/day) for a total 5–7 day course. - *Dosing may be age‑specific and protocol‑dependent; verify local guidelines.* ## Dose Adjustments - **Hepatic impairment:** No standard adjustment; use with caution (corticosteroid metabolism may be prolonged). - **Renal impairment:** No adjustment needed. - **Elderly:** Use lowest effective dose; monitor glucose and electrolytes closely. - **Adrenal insufficiency:** May require stress dose coverage; consult endocrinology. ## Contraindications - **Absolute:** Systemic fungal infection (e.g., candidemia), known hypersensitivity to hydrocortisone. - **Relative:** Active peptic ulcer, uncontrolled hypertension, severe diabetes, osteoporosis, recent live virus vaccination, or severe psychosis. ## Adverse Effects - **Short‑term:** Hyperglycemia, hypokalemia, hypertension, fluid retention, gastritis/peptic ulcer, psychiatric disturbances (anxiety, agitation, insomnia), increased infection risk. - **Long‑term (if prolonged):** Cushingoid features, adrenal suppression, osteoporosis, growth suppression in children, cataracts. - **Infusion‑related:** Phlebitis, pain at injection site, rare anaphylaxis. ## Key Drug Interactions - **NSAIDs/Aspirin:** Increased risk of GI bleeding. - **Diuretics (loop/thiazide):** Additive hypokalemia. - **Warfarin:** Possible altered anticoagulant effect (may increase or decrease INR). - **Antidiabetics:** May require dose escalation of insulin/oral agents. - **Barbiturates, phenytoin, rifampin:** Increased clearance of hydrocortisone (reduce its efficacy). ## Monitoring - **Blood glucose** (especially in diabetics or stress hyperglycemia). - **Serum potassium** (risk of hypokalemia with high doses). - **Blood pressure** (fluid/sodium retention). - **Clinical signs:** Heart rate, respiratory effort, O₂ saturation. - **Infection surveillance** (corticosteroids mask symptoms). - **Peak flow/FEV₁** to assess response. ## Clinical Pearls - **Timing:** Administer within 1 hour of presentation for best outcomes. - **Equivalent dose:** IV hydrocortisone 100 mg ≈ IV methylprednisolone 20 mg ≈ oral prednisolone 25 mg. - **Short‑course advantage:** No taper needed if used ≤7 days; abrupt stop is safe. - **Oral first:** If patient can swallow, oral prednisolone 40–50 mg single daily dose is equally effective, cheaper, and less risk of IV complications. - **Continuous infusion** may provide more stable levels but not proven superior to intermittent dosing. - **Pediatric note:** IV hydrocortisone is often replaced by IV methylprednisolone in many pediatric protocols; check hospital formulary. --- **Educational Disclaimer:** This information is for educational purposes only and does not replace professional clinical judgment. Always verify dosing against current institutional protocols, your local formulary, and up‑to‑date prescribing information.